← Back to Clinical Trials
Recruiting NCT06893458

NCT06893458 Feeding Difficulties and Quality of Life in Children With Tracheal Cannula

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06893458
Status Recruiting
Phase
Sponsor Karolinska Institutet
Condition Quality of Life (QOL)
Study Type OBSERVATIONAL
Enrollment 80 participants
Start Date 2025-03-17
Primary Completion 2027-03-17

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 18 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 80 participants in total. It began in 2025-03-17 with a primary completion date of 2027-03-17.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The over all goal of this observational study is to study if there is an association between the presence of feeding difficulties and self-assessed quality of life in children with tracheal cannula. The main questions it aims to answer are 1. What is the incidence of feeding difficulties in children with tracheostomy and what type of feeding difficulties affect these children? 2. How do children with a tracheal tube and their parents assess their quality of life measured through PedsQL? 3. Is there an association between the presence of feeding difficulties and self-assessed quality of life in children with tracheal cannula? Quality of life will be assessed in an interview using the PedsQL instrument generic module 4.0. Swallowing difficulties will be assessed through evaluations based on The Montreal Children's Hospital Feeding Scale.

Eligibility Criteria

Inclusion Criteria: Children below the age of 18 with tracheostomy undergoing follow-up through the Long term Intensive Care Unit at Karolinska University Hospital in Stockholm Sweden between march 2025 and march 2027. Exclusion criteria: Patients that can not undergo full evaluations/examinations will not be included.

Contact & Investigator

Central Contact

Ida Engqvist Engqvist, Medical Doctor

✉ ida.engqvist@regionstockholm.se

📞 +46 (+)768455333

Frequently Asked Questions

Who can join the NCT06893458 clinical trial?

This trial is open to participants of all sexes, up to 18 Years, studying Quality of Life (QOL). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06893458 currently recruiting?

Yes, NCT06893458 is actively recruiting participants. Contact the research team at ida.engqvist@regionstockholm.se for enrollment information.

Where is the NCT06893458 trial being conducted?

This trial is being conducted at Solna, Sweden, Solna, Sweden.

Who is sponsoring the NCT06893458 clinical trial?

NCT06893458 is sponsored by Karolinska Institutet. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology